| Catalog No. |
Size |
Price |
Figures |
|---|
Z00028-1 mg
| 1 mg | $ 420.00 |
References:
- Kusov Y, et al. Silencing of hepatitis A virus infection by small interfering RNAs. J. Virol. Jun 2006; 80(11): 5599-5610.
- Nainan OV, et al. iagnosis of hepatitis a virus infection: a molecular approach. Clin. Microbiol. Rev. Jan 2006; 19(1): 63-79.
- Fensterl V, et al. Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon. J. Virol. Sep 2005; 79(17): 10968-10977.
|
|---|
| Full Name | | Hepatitis A Virus (HAV) VP4-VP2 |
|
| Abbreviated Name-1 | Hepatitis VP4-VP2 |
|---|
| Description | Hepatitis A Virus (HAV) VP4-VP2 is an E. coli-derived recombinant. The protein contains the VP4-VP2 immunodominant region. HAV, the prototype of the genus Hepatovirus, belongs to the family Picornaviridae. Its 7.5-kb single-stranded RNA genome bears different distinct regions: the 5' and 3' noncoding regions (NCR), the P1 region, which encodes the structural proteins VP1, VP2, VP3, and a putative VP4, and the P2 and P3 regions encoding nonstructural proteins associated with replication. Hepatitis A Virus (HAV) VP4-VP2 encodes a single polyprotein which is posttranslationally processed into the functional structural and nonstructural proteins. |
|---|
| Source | E. coli |
|---|
| Purity | Protein is >90% pure as determined by 10% PAGE (coomassie staining). |
|---|
| Storage | Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
|---|
| Concentration | 1 mg/ml in 10 mM CBB, pH 9.6, 0.1% SDS, 50% glycerol |
|---|
| Stability | Five years frozen. one month in solution at room temperature. |
|---|
| Specificity | Immunoreactive with sera of HAV-infected individuals |
|---|
| Applications | Antigen in ELISA and Western blots, excellent antigen for detection of HAV with minimal specificity problems |
|---|
